Hanno B. Riess

机构：Charité - Universitätsmedizin Berlin

发表论文 518 篇 · 总被引 21768 次 · h-index 62

代表论文

• 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 (2022 · The Lancet Oncology · 被引 479)
• Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial (2022 · Journal of Clinical Oncology · 被引 142)
• The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta‐analysis (2020 · Journal of Thrombosis and Haemostasis · 被引 127)
• Recommendations for Clinical Trials in ICH (2020 · Stroke · 被引 66)
• TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial (2020 · Clinical Cancer Research · 被引 51)
• Advanced cancer is also a heart failure syndrome: a hypothesis (2020 · European Journal of Heart Failure · 被引 49)